Abiopharma

The Oncology Institute to Participate at the B. Riley Securities 25th Annual Institutional Investor Conference

NeuroPace Reports First Quarter 2025 Financial Results

Pharvaris Reports First Quarter 2025 Financial Results and Provides Business Update

MEI Pharma Reports Third Quarter Fiscal Year 2025 Cash Position

Iridex Reports First Quarter 2025 Financial Results

Absci Reports Business Updates and First Quarter 2025 Financial and Operating Results

New Form 10-Q - BIOADAPTIVES, INC. Filed: 2025-05-13 AccNo: 0001640334-25-000834 Size: 3 MB

New Form 8-K - Semler Scientific, Inc. Filed: 2025-05-13 AccNo: 0001554859-25-000018 Size: 670 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 8-K - Kezar Life Sciences, Inc. Filed: 2025-05-13 AccNo: 0001645666-25-000026 Size: 202 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 144 - HCA Healthcare, Inc. Filed: 2025-05-13 AccNo: 0001965353-25-000082 Size: 4 KB

Sellas Life Sciences - SELLAS Life Sciences Reports First Quarter 2025 Financial Results and Provides Corporate Update

New Form 8-K - MEI Pharma, Inc. Filed: 2025-05-13 AccNo: 0000950170-25-070298 Size: 581 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 8-K - CytomX Therapeutics, Inc. Filed: 2025-05-13 AccNo: 0001193125-25-118805 Size: 400 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 4 - NEOGENOMICS INC Filed: 2025-05-13 AccNo: 0001077183-25-000104 Size: 32 KB

New Form 8-K - AN2 Therapeutics, Inc. Filed: 2025-05-13 AccNo: 0000950170-25-070305 Size: 308 KB Item 9.01: Financial Statements and Exhibits